Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor PD Progression
View ORCID ProfileMichael C. Brumm, View ORCID ProfileAndrew Siderowf, View ORCID ProfileTanya Simuni, Elliot Burghardt, Seung Ho Choi, View ORCID ProfileChelsea Caspell-Garcia, Lana M. Chahine, Brit Mollenhauer, Tatiana Foroud, Douglas Galasko, Kalpana Merchant, Vanessa Arnedo, Samantha J. Hutten, Alyssa N. O’Grady, View ORCID ProfileKathleen L. Poston, Caroline M. Tanner, Daniel Weintraub, Karl Kieburtz, Kenneth Marek, Christopher S. Coffey Parkinson’s Progression Markers Initiative
doi: https://doi.org/10.1101/2023.05.23.23290344
Michael C. Brumm
aDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA
Andrew Siderowf
bDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Tanya Simuni
cDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Elliot Burghardt
aDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA
Seung Ho Choi
aDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA
Chelsea Caspell-Garcia
aDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA
Lana M. Chahine
dDepartment of Neurology, University of Pittsburgh, Pittsburgh, PA, USA
Brit Mollenhauer
eDepartment of Neurology, University Medical Center Goettingen, Goettingen, Germany
fParacelsus-Elena Klinik, Kassel, Germany
Tatiana Foroud
gDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA
Douglas Galasko
hDepartment of Neurology, University of California, San Diego, California, USA
Kalpana Merchant
cDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Vanessa Arnedo
iThe Michael J. Fox Foundation for Parkinson’s Research, New York, New York, USA
Samantha J. Hutten
iThe Michael J. Fox Foundation for Parkinson’s Research, New York, New York, USA
Alyssa N. O’Grady
iThe Michael J. Fox Foundation for Parkinson’s Research, New York, New York, USA
Kathleen L. Poston
jDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA
Caroline M. Tanner
kDepartment of Neurology, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA
lParkinson’s Disease Research, Education and Clinical Center, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA
Daniel Weintraub
bDepartment of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
mDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
nParkinson’s Disease Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA
Karl Kieburtz
oUniversity of Rochester Medical Center, University of Rochester, Rochester, NY, USA
Kenneth Marek
pInstitute for Neurodegenerative Disorders, New Haven, Connecticut, USA
Christopher S. Coffey
aDepartment of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA

Article usage
Posted May 24, 2023.
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor PD Progression
Michael C. Brumm, Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell-Garcia, Lana M. Chahine, Brit Mollenhauer, Tatiana Foroud, Douglas Galasko, Kalpana Merchant, Vanessa Arnedo, Samantha J. Hutten, Alyssa N. O’Grady, Kathleen L. Poston, Caroline M. Tanner, Daniel Weintraub, Karl Kieburtz, Kenneth Marek, Christopher S. Coffey
medRxiv 2023.05.23.23290344; doi: https://doi.org/10.1101/2023.05.23.23290344
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor PD Progression
Michael C. Brumm, Andrew Siderowf, Tanya Simuni, Elliot Burghardt, Seung Ho Choi, Chelsea Caspell-Garcia, Lana M. Chahine, Brit Mollenhauer, Tatiana Foroud, Douglas Galasko, Kalpana Merchant, Vanessa Arnedo, Samantha J. Hutten, Alyssa N. O’Grady, Kathleen L. Poston, Caroline M. Tanner, Daniel Weintraub, Karl Kieburtz, Kenneth Marek, Christopher S. Coffey
medRxiv 2023.05.23.23290344; doi: https://doi.org/10.1101/2023.05.23.23290344
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)